Ticker
IVVDCompany Name
INVIVYD INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt to Equity Ratio | Shareholders Equity | Total Liabilities |
---|---|---|---|
6/30/2025 | 1.08 | $ 42.79M | $ 46.35M |
3/31/2025 | 0.92 | $ 54.15M | $ 49.59M |
12/31/2024 | 0.92 | $ 67.54M | $ 61.98M |
9/30/2024 | 0.95 | $ 83.16M | $ 78.76M |
6/30/2024 | 0.26 | $ 140.64M | $ 36.7M |
3/31/2024 | 0.21 | $ 178.5M | $ 36.97M |
12/31/2023 | 0.29 | $ 177.47M | $ 51.71M |
9/30/2023 | 0.12 | $ 246.5M | $ 28.42M |
6/30/2023 | 0.12 | $ 281.56M | $ 33.85M |
3/31/2023 | 0.07 | $ 326.75M | $ 23.82M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Liabilities / Equity
(=) D/E
D/E for INVIVYD INC is calculated as follows: Liabilities [ $ 28.69M ] / Equity [ $ -103.36M ]
(=) D/E [ 0 ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.3K |
---|---|
min | 0 |
max | 6.05 |
average | 1.39 |
median | 0.98 |
std | 1.31 |